Found: 30
Select item for more details and to access through your institution.
Neoadjuvant Chemoradiation Impacts the Prognostic Effect of Surgical Margin Status in Pancreatic Adenocarcinoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 1, p. 354, doi. 10.1245/s10434-021-10219-3
- By:
- Publication type:
- Article
A phase 1b dose escalation study of Wnt pathway inhibitor vantictumab in combination with nab-paclitaxel and gemcitabine in patients with previously untreated metastatic pancreatic cancer.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 3, p. 821, doi. 10.1007/s10637-019-00824-1
- By:
- Publication type:
- Article
Association of Adiponectin and Vitamin D With Tumor Infiltrating Lymphocytes and Survival in Stage III Colon Cancer.
- Published in:
- JNCI Cancer Spectrum, 2021, v. 5, n. 5, p. 1, doi. 10.1093/jncics/pkab070
- By:
- Publication type:
- Article
Circulating tumor cells in colorectal cancer: past, present, and future challenges.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Progress in the development of prognostic and predictive markers for gastrointestinal malignancies.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trials.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
First-in-Human Phase 1b Trial of Quinacrine Plus Capecitabine in Patients With Refractory Metastatic Colorectal Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Safety and Efficacy of Radioembolization in Elderly (≥ 70 Years) and Younger Patients With Unresectable Liver-Dominant Colorectal Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Patterns of use and tolerance of anti-epidermal growth factor receptor antibodies in older adults with metastatic colorectal cancer.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Patterns of Use and Tolerance of Anti--Epidermal Growth Factor Receptor Antibodies in Older Adults With Metastatic Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2014, v. 13, n. 3, p. 192, doi. 10.1016/j.clcc.2014.05.003
- By:
- Publication type:
- Article
A Phase II Trial of the Proteasome Inhibitor Bortezomib in Patients With Advanced Biliary Tract Cancers.
- Published in:
- Clinical Colorectal Cancer, 2014, v. 13, n. 2, p. 81, doi. 10.1016/j.clcc.2013.12.005
- By:
- Publication type:
- Article
Emerging therapies for advanced gastroenteropancreatic neuroendocrine tumors.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Assessing Compliance with National Comprehensive Cancer Network Guidelines for Elderly Patients with Stage III Colon Cancer: The Fox Chase Cancer Center Partners' Initiative.
- Published in:
- Clinical Colorectal Cancer, 2011, v. 10, n. 2, p. 113, doi. 10.1016/j.clcc.2011.03.007
- By:
- Publication type:
- Article
Safety of trifluridine/tipiracil in an open-label expanded-access program in elderly and younger patients with metastatic colorectal cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase 1b study of erlotinib in combination with gemcitabine and nab-paclitaxel in patients with previously untreated advanced pancreatic cancer: an Academic Oncology GI Cancer Consortium study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 2, p. 287, doi. 10.1007/s00280-009-1162-y
- By:
- Publication type:
- Article
Phase I and pharmacokinetic study of the farnesyltransferase inhibitor R115777 in combination with irinotecan in patients with advanced cancer.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Patterns and predictors of failure following tri-modality therapy for locally advanced esophageal cancer.
- Published in:
- Acta Oncologica, 2016, v. 55, n. 3, p. 303, doi. 10.3109/0284186X.2015.1110252
- By:
- Publication type:
- Article
Chemotherapy use and adoption of new agents is affected by age and comorbidities in patients with metastatic colorectal cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 3204.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 3204
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 8, p. 1521, doi. 10.1002/cncr.27890
- By:
- Publication type:
- Article
Association of treatment factors with surgical outcomes in tri-modality therapy for esophageal cancer.
- Published in:
- Journal of Surgical Oncology, 2015, v. 112, n. 6, p. 629, doi. 10.1002/jso.24060
- By:
- Publication type:
- Article
Paclitaxel With or Without Cixutumumab as Second-Line Treatment of Metastatic Esophageal or Gastroesophageal Junction Cancer: A Randomized Phase II ECOG-ACRIN Trial.
- Published in:
- Oncologist, 2023, v. 28, n. 9, p. 827, doi. 10.1093/oncolo/oyad096
- By:
- Publication type:
- Article
A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus nab‐Paclitaxel and Gemcitabine in Advanced Solid Tumors.
- Published in:
- Oncologist, 2019, v. 24, n. 1, p. 14, doi. 10.1634/theoncologist.2017-0665
- By:
- Publication type:
- Article
Phase II Study of Olaparib (AZD-2281) After Standard Systemic Therapies for Disseminated Colorectal Cancer.
- Published in:
- Oncologist, 2016, v. 21, n. 2, p. 172, doi. 10.1634/theoncologist.2015-0319
- By:
- Publication type:
- Article
Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204.
- Published in:
- Oncologist, 2015, v. 20, n. 6, p. 615, doi. 10.1634/theoncologist.2015-0106
- By:
- Publication type:
- Article
Circulating Tumor Cells: Evolving Evidence and Future Challenges.
- Published in:
- Oncologist, 2009, v. 14, n. 11, p. 1070, doi. 10.1634/theoncologist.2009-0094
- By:
- Publication type:
- Article
Young Age Increases Risk of Lymph Node Positivity in Early-Stage Rectal Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Comment on "Epidermal Growth Factor Receptor Is Essential for Toll-Like Receptor 3 Signaling".
- Published in:
- Science Signaling, 2012, v. 5, n. 254, p. 1, doi. 10.1126/scisignal.2003734
- By:
- Publication type:
- Article